Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2014

01.06.2014 | Original Article

Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population

verfasst von: Naoki Shiraishi, Kenichiro Kitamura, Yukimasa Kohda, Kunitoshi Iseki, Kimio Tomita

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Nephrosclerosis/ischemic nephropathy (NS/IN) ranks third among renal diseases requiring dialysis in Japan. Although it is an important renal disease in terms of frequency, its prevalence, new incidence, and risk factors are not fully elucidated.

Methods

We analyzed the prevalence, incidence, concurrent diseases, and risk factors of NS/IN by using data from specific health checkups of Kumamoto citizens between 2008 and 2010.

Results

Although the prevalence of NS/IN was 1−2 % in people in their 40s, it increased sharply with age, reaching 17.6 % in people aged 70–74 years. The incidence of new NS/IN was 0.4−0.5 % per year. In multivariate logistic regression analysis, factors such as age, male gender, body mass index (BMI), hyperuricemia, hypertension, and dyslipidemia correlated with NS/IN. When risk factors associated with NS/IN progress were evaluated by multivariate logistic regression analysis, four factors—male gender, hypertension, BMI, and current smoking—significantly correlated.

Conclusion

The analysis of Kumamoto citizens aged 40–74 years receiving specific health checkups showed that in addition to hypertension and age that were considered important, male gender and obesity are also risk factors for NS/IS independent from hypertension.
Literatur
1.
Zurück zum Zitat Szwed JJ. Urinalysis and clinical renal disease. Am J Med Technol. 1980;46:720–5.PubMed Szwed JJ. Urinalysis and clinical renal disease. Am J Med Technol. 1980;46:720–5.PubMed
2.
Zurück zum Zitat Takebayashi S, Kiyoshi Y, Hisano S, Uesugi N, Sasatomi Y, Meng J, Sakata N. Benign nephrosclerosis: incidence, morphology and prognosis. Clin Nephrol. 2001;55:349–56.PubMed Takebayashi S, Kiyoshi Y, Hisano S, Uesugi N, Sasatomi Y, Meng J, Sakata N. Benign nephrosclerosis: incidence, morphology and prognosis. Clin Nephrol. 2001;55:349–56.PubMed
3.
Zurück zum Zitat Lerman LO, Textor SC, Grande JP. Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. Prog Cardiovasc Dis. 2009;52:196–203.PubMedCentralPubMedCrossRef Lerman LO, Textor SC, Grande JP. Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. Prog Cardiovasc Dis. 2009;52:196–203.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Zucchelli P, Zuccalà A. Recent data on hypertension and progressive renal disease. J Hum Hypertens. 1996;10:679–82.PubMed Zucchelli P, Zuccalà A. Recent data on hypertension and progressive renal disease. J Hum Hypertens. 1996;10:679–82.PubMed
5.
Zurück zum Zitat The Committee of Japanese Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010;53:450–67. The Committee of Japanese Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010;53:450–67.
6.
Zurück zum Zitat Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi. 2005;94:794–809.CrossRef Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi. 2005;94:794–809.CrossRef
7.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan; Collaborators developing the Japanese equation for estimated GFR. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan; Collaborators developing the Japanese equation for estimated GFR. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef
8.
Zurück zum Zitat Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.PubMedCrossRef Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.PubMedCrossRef
9.
Zurück zum Zitat Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–11.PubMedCrossRef Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–11.PubMedCrossRef
10.
Zurück zum Zitat Diez Ojea B, Marín R, Coto E, Fernández Vega F, Alvarez Navascués R, Fernández Fresnedo G, Pobes Martínez de Salinas A, Suárez Laurés A, García Monteavaro C, Gorostidi M, Sánchez E, Arias M, Ortega F. Clinical and genetic basis of hypertensive nephrosclerosis. NEFROSEN study. Nefrologia. 2010;30:687–97.PubMed Diez Ojea B, Marín R, Coto E, Fernández Vega F, Alvarez Navascués R, Fernández Fresnedo G, Pobes Martínez de Salinas A, Suárez Laurés A, García Monteavaro C, Gorostidi M, Sánchez E, Arias M, Ortega F. Clinical and genetic basis of hypertensive nephrosclerosis. NEFROSEN study. Nefrologia. 2010;30:687–97.PubMed
11.
Zurück zum Zitat Kalaitzidis RG, Siamopoulos KC. The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol. 2011;43:771–84.PubMedCrossRef Kalaitzidis RG, Siamopoulos KC. The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol. 2011;43:771–84.PubMedCrossRef
12.
Zurück zum Zitat Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44:642–50.PubMedCrossRef Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44:642–50.PubMedCrossRef
13.
Zurück zum Zitat Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant. 1997;12:1908–15.PubMedCrossRef Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant. 1997;12:1908–15.PubMedCrossRef
14.
Zurück zum Zitat Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159–66.PubMedCrossRef Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159–66.PubMedCrossRef
15.
Zurück zum Zitat Noborisaka Y, Ishizaki M, Yamada Y. Paradoxical signs of smoking-induced chronic kidney disease (CKD) in generally healthy populations, especially those from workplaces. J Kanazawa Med Univ. 2011;36:98–105. Noborisaka Y, Ishizaki M, Yamada Y. Paradoxical signs of smoking-induced chronic kidney disease (CKD) in generally healthy populations, especially those from workplaces. J Kanazawa Med Univ. 2011;36:98–105.
16.
Zurück zum Zitat Marín R, Gorostidi M, Fernández-Vega F, Alvarez-Navascués R. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int Suppl. 2005:S52–56. Marín R, Gorostidi M, Fernández-Vega F, Alvarez-Navascués R. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int Suppl. 2005:S52–56.
17.
Zurück zum Zitat Tomson CR, Petersen K, Heagerty AM. Does treated essential hypertension result in renal impairment? A cohort study. J Hum Hypertens. 1991;5:189–92.PubMed Tomson CR, Petersen K, Heagerty AM. Does treated essential hypertension result in renal impairment? A cohort study. J Hum Hypertens. 1991;5:189–92.PubMed
18.
Zurück zum Zitat Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens. 2001;15:99–106.PubMedCrossRef Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens. 2001;15:99–106.PubMedCrossRef
Metadaten
Titel
Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population
verfasst von
Naoki Shiraishi
Kenichiro Kitamura
Yukimasa Kohda
Kunitoshi Iseki
Kimio Tomita
Publikationsdatum
01.06.2014
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2014
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0833-5

Weitere Artikel der Ausgabe 3/2014

Clinical and Experimental Nephrology 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.